CXCR4, or C-X-C Chemokine Receptor Type 4, is a highly conserved G-protein-coupled receptor (GPCR) primarily involved in cellular migration, immune responses, and tissue repair. CXCR4 is one of the most studied chemokine receptors due to its role in various diseases, including cancer, liver disease, and HIV infection.1, 2 CXCR4’s primary ligand, CXCL12 (also known as SDF-1 or stromal cell-derived factor 1), binds exclusively to CXCR4, forming the CXCL12/CXCR4 axis, which regulates many physiological and pathological processes.3, 2
History of CXCR4 Discovery
CXCR4 was initially identified as an orphan receptor and given the name LESTR, standing for leukocyte-derived seven-transmembrane domain receptor. It garnered significant attention when discovered as a coreceptor for HIV-1, facilitating viral entry into host cells along with the primary receptor, CD4. Following this, researchers identified CXCL12 as its natural ligand, revealing the critical functions of the CXCL12/CXCR4 axis in immune response, cellular migration, and organ development.2
What Does CXCR4 Stand For?
CXCR4 stands for “C-X-C Chemokine Receptor Type 4.” It belongs to the chemokine receptor family and is named according to the chemokine ligand (CXCL12) it binds. The “C-X-C” classification indicates the chemokine structure, specifically that there is one amino acid between the two cysteine residues in its motif, distinguishing it from other chemokine classes like CC, C, and CX3C.4,2
What Do CXCR4 Proteins Do?
CXCR4 proteins are involved in critical cellular processes including immune cell trafficking, hematopoiesis, and organogenesis. This receptor, upon binding with CXCL12, activates downstream signaling pathways that influence cell survival, migration, and proliferation. CXCR4 is also known for its roles in cancer progression, as it aids tumor cells in metastasizing to organs that express high levels of CXCL12, including the lungs, liver, and bone marrow.1,4
Function and Importance of the CXCR4 Protein
The CXCR4 protein has several vital functions in health and disease:
Cell Migration and Immune Cell Trafficking: CXCR4 is critical for directing immune cells to sites of infection or injury guiding the cell towards regions of CXCL12 concentration, chemotactic function. It helps maintain immune surveillance by regulating the movement of hematopoietic stem cells (HSCs) within the bone marrow.3
Cancer Metastasis: CXCR4 is highly expressed in various cancers, where it facilitates tumor cell migration and metastasis to organs with abundant CXCL12 expression. Inhibiting CXCR4 has shown promise in pre-clinical models for reducing cancer spread, positioning CXCR4 as a therapeutic target for metastatic cancers.1,4
HIV Entry: As a co-receptor for HIV-1, CXCR4 is a key player in viral entry into host cells. Certain HIV strains specifically target CXCR4 to enter cells, making this receptor a key focus in antiviral research.2
Clinical Applications and Therapeutic Potential
Given its involvement in cancer, immune responses, and viral infections, CXCR4 has emerged as a therapeutic target across several fields:
Cancer Therapy: Small molecule inhibitors and antibodies targeting CXCR4 have been developed, with Plerixafor (AMD3100) being an FDA-approved drug used to mobilize hematopoietic stem cells. Other CXCR4 antagonists are under investigation to inhibit metastasis in cancers such as breast, liver, and lung cancers.4
Antiviral Therapy: Targeting CXCR4 to prevent HIV from entering cells is a potential therapeutic approach. Current research is exploring agents that block CXCR4 without disrupting its normal functions to reduce HIV infection rates.2
Liver Disease: CXCR4 and its ligand CXCL12 play a crucial role in liver disease by influencing the migration and activation of liver-specific cells. This pathway’s modulation may provide new therapeutic avenues for treating liver fibrosis and cirrhosis.3
Special Characteristics of CXCR4
CXCR4 exhibits unique characteristics that distinguish it from other chemokine receptors:
Selective Ligand Binding: Unlike many chemokine receptors, CXCR4 has a high specificity for primary ligand CXCL12, leading to distinct signaling pathways that regulate critical cellular processes.2
Structural Specificity and Stability: CXCR4’s seven-transmembrane GPCR structure is highly conserved, with unique phosphorylation sites on the C-terminal region. This structure enables CXCR4 to interact with specific signaling molecules and maintain stability across different cell types and conditions.1
High Expression in Hypoxic Environments: CXCR4 expression is upregulated under hypoxic conditions, a characteristic that contributes to its role in cancer progression and metastasis as tumors often create low-oxygen environments that stimulate CXCR4 activity.4
Other Notable Names
CXCR4 is also referred to as CD184, highlighting its classification within the broader cluster of differentiation (CD) nomenclature for cell surface proteins. The receptor’s initial identification as LESTR (leukocyte-derived seven-transmembrane receptor) reflects its discovery as a key player in immune cell trafficking.2
Conigen’s Innovative Approach to CXCR4 Expression and Applications
As a 7-transmembrane protein GPCR, the expression of CXCR4 as a recombinant protein is very challenging. The complex structure makes it difficult to maintain proper folding and functional conformation, as well as results in low expression levels and poor stability. To overcome these hurdles, Conigen has innovatively designed and engineered CXCR4-CMP, displaying the CXCR4 protein on nanoparticles, non-infectious viral-like particles (VLPs). The CXCR4 molecule is embedded in the lipid bilayer supported by a viral capsid protein core, which forms VLP nanoparticles (150-200 nm). A high density of CXCR4 molecules displayed in the outer shell lipid bilayer of the VLP mimics the natural conformation displayed on mammalian cell membranes.
The CXCR4-CMP is stable and bioactive. It can be specifically and potently bound by CXCR4-specific antibodies, and more importantly, it can bind to its ligand CXCL12 and HIV-1 envelope glycoprotein. This innovative CXCR4-CMP offers a versatile and efficient platform for conducting in vivo animal immunization and in vitro bioassays in areas such as receptor-ligand interactions, drug screening, and mechanistic studies. Their safety, ease of production, and adaptability make them valuable tools for both basic research and pharmaceutical applications.
References
- Gary D Luker, Jinming Yang, Ann Richmond, Stefania Scala, Claudio Festuccia, Margret Schottelius, Hans-Jürgen Wester, Johann Zimmermann, At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer, Journal of Leukocyte Biology, Volume 109, Issue 5, May 2021, Pages 969–989, https://doi.org/10.1002/JLB.2BT1018-715RR
- Alkhatib G. (2009). The biology of CCR5 and CXCR4. Current opinion in HIV and AIDS, 4(2), 96–103. https://doi.org/10.1097/COH.0b013e328324bbec
- Wang, S., Gao, S., Li, Y., Qian, X., Luan, J., & Lv, X. (2021). Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease. Frontiers in cell and developmental biology, 9, 716842. https://doi.org/10.3389/fcell.2021.716842
- Zhao, R., Liu, J., Li, Z., Zhang, W., Wang, F., & Zhang, B. (2022). Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics, 14(8), 1541. https://doi.org/10.3390/pharmaceutics14081541
